Abdul Mannan on Finding the Right Balance – The Blood Thinner Dilemma
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Stopping blood thinners after a clot is tricky. You might stop too soon and get another clot. Or you might stay on them too long and bleed.
We used to rely on fancy scores and tests. Now guidelines say don’t bother with most of them. Just talk to your patient.
If the clot had no clear cause, you probably need longer treatment. If it happened after surgery, you can stop sooner.
Cancer patients stay on treatment whilst the cancer is active. Simple as that.
Three months treats the clot. After that, you’re preventing the next one. That’s when the hard choices start.
Some tools help predict risk. But ASH says use them only if they’ll actually change your plan. Otherwise, skip them.
Lower doses work for prevention after the first months. Balance is everything.”
Stay updated with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025